DOCSLIB.ORG

Menstrual Cycle Disorders

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

MenstrualMenstrual cyclecycle disordersdisorders DrDr DD ChardonnensChardonnens PDPD DefinitionsDefinitions SecondarySecondary amenorrheaamenorrhea 33 consecutiveconsecutive monthsmonths withoutwithout periodsperiods PrimaryPrimary amenorrheaamenorrhea NoNo periodsperiods afterafter thethe ageage ofof 1616 –– 1717 HypomenorrheaHypomenorrhea PeriodsPeriods << 33 daysdays withwith littlelittle bleedingbleeding DefinitionsDefinitions MenorrhagiaMenorrhagia PeriodsPeriods >> 77 daysdays && >> 8080 mlml HypermenorrheaHypermenorrhea PeriodsPeriods >> 8080 mlml OligomenorrheaOligomenorrhea CycleCycle >> 3535 daysdays PolymenorrheaPolymenorrhea CycleCycle << 2121 daysdays DefinitionsDefinitions PrimaryPrimary dysmenorrheadysmenorrhea PainfulPainful periodsperiods beforebefore thethe ageage ofof 1919 SecondarySecondary dysmenorrheadysmenorrhea PainfulPainful periodsperiods afterafter thethe ageage ofof 1919 DifferentDifferent levelslevels CNS I Hypothalamus II Pituitary Thyroid Adrenal III Ovary Uterus IV PFP LFP PLP MLP LLP HormonalHormonal assays:assays: FSHFSH Prognostic value of day 3 FSH levels in 758 patients undergoing an IVF cycle Adapted from Scott et al. 1989, Fertil. Steril., 51 651 -654 25 Total Delivery 20 er cycle (%) 15 cy rate p 10 5 Pregnan 0 <15 15 - 24,9 > 25 Basal day 3 FSH (mIU / mL) HormonalHormonal assays:assays: LHLH DayDay 33 LHLH >> 1010 IU/L,IU/L, oror LH/FSHLH/FSH >> 2.52.5 infertility spontaneous abortions PCOS PFP LFP PLP MLP LLP BasalBasal BodyBody TemperatureTemperature ↑↑ basalbasal bodybody temperaturetemperature ≥≥ 0.20.2°°CC ↑↑ basalbasal bodybody temperaturetemperature ≥≥ 1212 daysdays BasalBasal BodyBody TemperatureTemperature InexpensiveInexpensive RepeatedRepeated inin differentdifferent cyclescycles NotNot appropriateappropriate toto timetime ovulationovulation PoorPoor correlationcorrelation withwith PP levellevel andand endometrialendometrial biopsiesbiopsies BasalBasal bodybody temperaturetemperature BasalBasal bodybody temperaturetemperature BasalBasal bodybody temperaturetemperature HormonalHormonal assays:assays: ProgesteroneProgesterone DayDay 2121 2.5 - 5 ng / ml ovulation 10 - 15 ng / ml normal corpus luteal function DayDay 20,20, 21,21, 2222 Σ : 15 ≥ ng/ ml EndometrialEndometrial biopsybiopsy DifferentDifferent levelslevels MRI, I FSH & LH indirect evidence of GnRH II FSH, LH, TSH, Prl MRI Thyroid Adrenals E2 P4 A2 T III Echography βhCG Echography IV MRI Hysteroscopy Progestin test SomeSome etiologiesetiologies ofof secondarysecondary amenorrheaamenorrhea Stress I Anorexia… II Tumors Necrosis… PCO III Menopause… Pregnancy IV Synechiae Stenosis TBC… InvestigatingInvestigating secondarysecondary amenorrheaamenorrhea ExcludeExclude pregnancypregnancy normogonadicnormogonadic amenorrheaamenorrhea EE2 >> 3030 pgpg/ml/ml HypogonadicHypogonadic amenorrheaamenorrhea EE2 << 3030 pgpg/ml/ml Hypergonadotropic (primary hypogonadism) FSH > 20 – 30 UI/L Hypogonadotropic (secondary hypogonadism) LH < 1 UI/L CaseCase 11 2525 yearsyears oldold athleteathlete withwith secondarysecondary amenorrheaamenorrhea afterafter stoppingstopping OCOC (>(> 1212 monthsmonths)) InvestigationsInvestigations PregnancyPregnancy testtest –– EE2 2525 pgpg/ml/ml FSHFSH == 22 UI/L,UI/L, LHLH 0.20.2 UI/LUI/L PrlPrl NN DiagnosisDiagnosis:: HypogonadotropicHypogonadotropic hypogonadismhypogonadism hypothalamichypothalamic amenorrheaamenorrhea CaveCave bonebone massmass CaseCase 22 2525 yearsyears oldold athleteathlete withwith secondarysecondary amenorrheaamenorrhea afterafter stoppingstopping OCOC (>(> 1212 monthsmonths)) hothot flushesflushes InvestigationsInvestigations PregnancyPregnancy testtest –– EE2 2525 pgpg/ml/ml FSHFSH == 5252 UI/L,UI/L, LHLH 2525 UI/LUI/L PrlPrl NN DiagnosisDiagnosis HypergonadotropicHypergonadotropic hypogonadismhypogonadism:: precociousprecocious menopausemenopause CaseCase 22 OtherOther investigationsinvestigations TestTest otherother endocrineendocrine pathwayspathways TestTest forfor autoimmuneautoimmune diseasesdiseases TestTest forfor geneticgenetic diseasesdiseases (X(X fragile,fragile, TurnerTurner…….).) CounsellingCounselling THSTHS CaseCase 33 2525 yearsyears oldold athleteathlete withwith secondarysecondary amenorrheaamenorrhea afterafter stoppingstopping OCOC (>(> 1212 monthsmonths)) HistoryHistory ofof irregularirregular cyclescycles InvestigationsInvestigations PregnancyPregnancy testtest –– EE2 105105 pgpg/ml/ml FSHFSH == 44 UI/L,UI/L, LHLH 1414 UI/LUI/L PrlPrl NN DiagnosisDiagnosis «« NormogonadicNormogonadic »» amenorrheaamenorrhea CaseCase 33 InvestigationsInvestigations T = 0.9 ng/ml 17 OH-P = 250 ng/dl ACTH testing 17 OH-P = 450 ng/dl Ultrasound PCOPCO ?? PCOSPCOS • Ultrasound criteria • Infertility 88 % • Insulin resistance 70 % • Hirsutism 62 % • Irregular cycles 50 % • Obesity 38 % • Acne 35 % PCOPCO andand ultrasoundultrasound criteriacriteria ↑ ovarian volume ↑ ovarian stroma > 10 follicles Ø <10 mm at the periphery (necklace sign) PCOPCO andand ultrasoundultrasound criteriacriteria van Santbrink et al. 1997 Fertil Steril ↑ Follicle number (58%) ↑ Ovarian stroma (45%) 9 10 15 23 3 11 4 ↑ Ovarian volume (41%) PCOPCO versusversus PCOSPCOS van Santbrink et al. 1997 Fertil Steril Ultrasound criteria (66%) 21 8 20 5 ↑ Androgens (36 %) 17 3 7 ↑ LH (47%) AndrogensAndrogens DHEAS 90 % 10 % DHEA 60 % Androstenedione 40 % DHEA Ovary Adrenal Peripheral tissue 25 % 50 % 25 % Testosterone SerumSerum valuesvalues ofof androgensandrogens DHEA-S Androstenedione Testosterone ng/ml ng/ml ng/ml Premenopause 1600 1.4 0.4 (500 - 2800) (0.7 - 3.1) (0.2 - 0.8) Menopause 800 0.8 0.15 (0.1 - 2.7) (0.1 - 0.4) Term 320 2.4 4.0 pregnancy AndrogensAndrogens andand seriousserious diseasedisease TestosteroneTestosterone >> 22 ngng/ml/ml Look for tumor of the ovary DHEASDHEAS >> 70007000 ngng/ml/ml Look for tumor of the adrenal 1717 OHOH--PP andand menstrualmenstrual cyclecycle 3 2 IU/L 1 17 OH-P 0 0 4 8 1216202428 Menses Cycle Day BasalBasal valuesvalues forfor 1717 OHOH--PP >> 800800 ngng/dl/dl (24(24 nmolnmol/l)/l) 2121 hydroxylasehydroxylase deficiencydeficiency >> 200200 ngng/dl/dl (6(6 nmolnmol/l)/l) SuspicionSuspicion ofof 2121 hydroxylasehydroxylase deficiencydeficiency TestTest withwith ACTHACTH << 200200 ngng/dl/dl (6nmol/l)(6nmol/l) 2121 hydroxylasehydroxylase deficiencydeficiency 1717 OHOH--PP postpost ACTHACTH >> 15001500 ngng/dl/dl LateLate onsetonset adrenaladrenal hyperplasiahyperplasia 10001000--15001500 ngng/dl/dl SuspicionSuspicion ofof latelate onsetonset hyperplasiahyperplasia GeneGene 21B21B analysisanalysis << 10001000 ngng dldl HeterozygoteHeterozygote carriercarrier CaseCase 33 CaveCave InfertilityInfertility DevelopmentDevelopment ofof diabetesdiabetes typetype 22 IncreaseIncrease inin cardiovascularcardiovascular eventsevents ?? HyperplasiaHyperplasia andand endometrialendometrial carcinomacarcinoma CaseCase 44 2525 yearsyears oldold athleteathlete withwith secondarysecondary amenorrheaamenorrhea afterafter stoppingstopping OCOC (>(> 1212 monthsmonths)) HistoryHistory ofof headachesheadaches andand visualvisual disturbancesdisturbances InvestigationsInvestigations PregnancyPregnancy testtest –– EE2 2828 pgpg/ml/ml FSHFSH == 44 UI/L,UI/L, LHLH 11 UI/LUI/L PrlPrl 150150 ngng/ml/ml DiagnosisDiagnosis HypogonadicHypogonadic amenorrheaamenorrhea withwith hyperprolactinemiahyperprolactinemia CaseCase 44 DDDD ofof hyperprolactinemiahyperprolactinemia StressStress MedicationMedication (neurotropes,(neurotropes, estrogenesestrogenes…….).) HypothyroidHypothyroid statestate NeurogenicNeurogenic ((breastbreast palpation,palpation, intercostalintercostal zona..)zona..) HypothalamicHypothalamic disordersdisorders PituitaryPituitary disordersdisorders CaseCase 55 2525 yearsyears oldold athleteathlete withwith secondarysecondary amenorrheaamenorrhea afterafter stoppingstopping OCOC (>(> 1212 monthsmonths).). HistoryHistory ofof postpartumpostpartum hemorrhagehemorrhage withwith retainedretained placentaplacenta InvestigationsInvestigations PregnancyPregnancy testtest –– EE2 174174 pgpg/ml/ml FSHFSH == 2525 UI/L,UI/L, LHLH 5858 UI/LUI/L PrlPrl NN DiagnosisDiagnosis NormogonadicNormogonadic hypergonadotropichypergonadotropic amenorrheaamenorrhea CaseCase 55 UltrasoundUltrasound PP4 == 6,26,2 ngng/ml/ml CaseCase 55 HysterosalpingographyHysterosalpingography HysteroscopyHysteroscopy CaseCase 66 2525 yearsyears oldold athleteathlete withwith secondarysecondary amenorrheaamenorrhea afterafter stoppingstopping OCOC (>(> 1212 monthsmonths).). HistoryHistory ofof postpartumpostpartum hemorrhagehemorrhage withwith retainedretained placenta.placenta. SheShe couldcould notnot breastfeedbreastfeed.. InvestigationsInvestigations Pregnancy test – E2 10 pg/ml FSH = 1 UI/L, LH 0.2 UI/L Prl 4 ng/mL DiagnosisDiagnosis Hypogonadic hypogonadotropic amenorrhea CaseCase 66 SheehanSheehan SyndromeSyndrome TestTest thethe endocrineendocrine axisaxis CNSCNS MRIMRI HormonalHormonal substitutionsubstitution accordingaccording toto thethe endocrineendocrine deficitsdeficits CaseCase 77 4242 yearyear oldold ladylady complainingcomplaining ofof menorrhagiamenorrhagia andand secondarysecondary dysmenorrheadysmenorrhea sincesince 22 yearsyears Normal pelvic examination PAP smear normal TVSTVS andand HTVSHTVS HTVSHTVS vsvs hysteroscopyhysteroscopy TVSTVS HTVSHTVS HysteroscoppyHysteroscoppy CaseCase 88 5959 yearyear oldold womenwomen onon sequentialsequential HRTHRT complainigcomplainig
Recommended publications
  • Non Hormonal Management of Menstrual Cylce Irregularities

    Non Hormonal Management of Menstrual Cylce Irregularities

    Journal of Gynecology and Women’s Health ISSN 2474-7602 Review Article J Gynecol Women’s Health Volume 11 Issue 4 - September 2018 Copyright © All rights are reserved by Arif A Faruqui DOI: 10.19080/JGWH.2018.11.555818 Non Hormonal Management of Menstrual Cylce Irregularities Arif A Faruqui* Department of Pharmacology, Clinical Pharmacologist, A 504, Rizvi Mahal, India Submission: August 16, 2018; Published: September 07, 2018 *Corresponding author: Email: Arif A Faruqui, Department of Pharmacology, A 504, Rizvi Mahal Opp. K.B. Bhabha Hospital, Waterfield road Bandra, India, Abstract of bleedingEach month patterns, the endometriumfor example, amenorrhea, becomes inflamed, menorrhagia and the or luminalpolymenorrhea; portion ovarianis shed dysfunctionduring menstruation. for example, Aberrations anovulation in menstrualand luteal physiology can lead to common gynecological conditions, such as heavy or prolonged bleeding. Menstrual dysfunction is defined in terms pathologic process or may predispose a woman to the development of chronic disease. For example, metrorrhagia predisposes to anemia, anddeficiency; the irregular painful menstrual menstruation cycles and associated premenstrual with PCOS syndrome. (see PCOS) Certain can characteristics predispose a woman of menstruation to infertility, can diabetes be a reflection and consequently, of an underlying heart disease. What is it, in this age of life-saving antibiotics, hormonal therapy, surgeries and other seemingly miraculous medical therapies that causes so many individuals to seek therapies outside of conventional medicine? Conventional medicine may be at its best when treating acute crises, but for the treatment of chronic problems it may fall short of offering either cure or healing, leading patients to seek out systems of treatment that they perceive as addressing the causes of their problem, not just the symptoms.
  • The Prevalence of and Attitudes Toward Oligomenorrhea and Amenorrhea in Division I Female Athletes

    The Prevalence of and Attitudes Toward Oligomenorrhea and Amenorrhea in Division I Female Athletes

    POPULATION-SPECIFIC CONCERNS The Prevalence of and Attitudes Toward Oligomenorrhea and Amenorrhea in Division I Female Athletes Karen Myrick, DNP, APRN, FNP-BC, Richard Feinn, PhD, and Meaghan Harkins, MS, BSN, RN • Quinnipiac University Research has demonstrated that amenor- hormone and follicle-stimulating hormone rhea and oligomenorrhea may be common shut down stimulation to the ovary, ceasing occurrences among female athletes.1 Due production of estradiol.2 to normalization of menstrual dysfunction The effect of oral contraceptives on the within the sport environment, amenorrhea menstrual cycle include ovulation inhibi- and oligomenorrhea tion, changes in cervical mucus, thinning may be underreported. of the uterine endometrium, and motility Key PointsPoints There are many underly- and secretion in the fallopian tubes, which Lean sport athletes are more likely to per- ing causes of menstrual decrease the likelihood of conception and 3 ceive missed menstrual cycles as normal. dysfunction. However, implantation. Oral contraceptives contain a a similar hypothalamic combination of estrogen and progesterone, Menstrual dysfunction is one prong of the amenorrhea profile is or progesterone only; thus, oral contracep- female athlete triad. frequently seen in ath- tives do not stop the production of estrogen. letes, and hypothalamic Menstrual dysfunction is one prong of the Menstrual dysfunction is often associated dysfunction is com- female athlete triad (triad). The triad is a with musculoskeletal and endothelial monly the root of ath- syndrome of linking low energy availability compromise. lete’s menstrual abnor- (EA) with or without disordered eating, men- malities.2 The common strual disturbances, and low bone mineral Education and awareness of the accultur- hormone pattern for density, across a continuum.
  • Prevalence of Menstrual Irregularities in Correlation with Body Fat Among Students of Selected Colleges in a District of Tamil Nadu, India

    Prevalence of Menstrual Irregularities in Correlation with Body Fat Among Students of Selected Colleges in a District of Tamil Nadu, India

    National Journal of Physiology, Pharmacy and Pharmacology RESEARCH ARTICLE Prevalence of menstrual irregularities in correlation with body fat among students of selected colleges in a district of Tamil Nadu, India Sherly Deborah G1, Siva Priya D V2, Rama Swamy C2 1Department of Physiology, Faculty of Medicine, AIMST University, Bedong, Kedah, Malaysia, 2Department of Physiology, Saveetha Medical College, Chennai, Tamil Nadu, India Correspondence to: Sherly Deborah G, E-mail: [email protected] Received: March 05, 2017; Accepted: March 22, 2017 ABSTRACT Background: Menstrual irregularities are usually due to imbalance of hormones. Although menstrual irregularities may be normal during the early postmenarchal years, pathological conditions require proper and prompt management. Obesity associated with many health consequences including hormonal imbalance has a direct effect on menstrual cycle. Hence, attention to obesity is obligatory for the inclusion of diagnosis and treatment of menstrual complaints which has become a leading issue in women’s life. Aims and Objectives: The aims and objectives of the study are to assess the menstrual irregularities and to find the association between menstrual irregularities and body fat among students. Materials and Methods: A cross-sectional study was conducted in three selected colleges in a district of Tamil Nadu in India. A total of 399 samples were included in the study. A 10-item questionnaire was administered to assess the menstrual irregularity in each student. The demographic variables along with anthropometric measurements were collected. Anthropometric measurements were taken to calculate the body fat percentage using modified YMCA formula. Results: The prevalence of menstrual irregularities was high in obesity compared with those with normal body fat and particularly oligomenorrhea, amenorrhea, and hypomenorrhea had statistically significant increase in obese students.
  • (IJCRI) Abdominal Menstruation

    (IJCRI) Abdominal Menstruation

    www.edoriumjournals.com CASE SERIES PEER REVIEWED | OPEN ACCESS Abdominal menstruation: A dilemma for the gynecologist Seema Singhal, Sunesh Kumar, Yamini Kansal, Deepika Gupta, Mohit Joshi ABSTRACT Introduction: Menstrual fistulae are rare. They have been reported after pelvic inflammatory disease, pelvic radiation therapy, trauma, pelvic surgery, endometriosis, tuberculosis, gossypiboma, Crohn’s disease, sepsis, migration of intrauterine contraceptive device and other pelvic pathologies. We report two rare cases of menstrual fistula. Case Series: Case 1: A 27- year-old nulliparous female presented with complaint of cyclical bleeding from the abdomen since three years. There was previous history of hypomenorrhea and cyclical abdominal pain since menarche. There is history of laparotomy five years back and laparoscopy four years back in view of pelvic mass. Soon after she began to have blood mixed discharge from scar site which coincided with her menstruation. She was diagnosed to have a vertical fusion defect with communicating left hypoplastic horn and non-communicating right horn on imaging. Laparotomy with excision of fistula and removal of right hematosalpinx was done. Case 2: 25-year-old female presented with history of lower segment caesarean section (LSCS) and burst abdomen, underwent laparotomy and loop ileostomy. Thereafter patient developed cyclical bleeding from scar site. Laparotomy with excision of fistulous tract and closure of uterine rent was done. Conclusion: Clinical suspicion and imaging help to clinch the diagnosis. There is no recommended treatment modality. Surgery is the mainstay of management. Complete excision of fistulous tract is mandatory for good long-term outcomes. International Journal of Case Reports and Images (IJCRI) International Journal of Case Reports and Images (IJCRI) is an international, peer reviewed, monthly, open access, online journal, publishing high-quality, articles in all areas of basic medical sciences and clinical specialties.
  • Vaginitis and Abnormal Vaginal Bleeding

    Vaginitis and Abnormal Vaginal Bleeding

    UCSF Family Medicine Board Review 2013 Vaginitis and Abnormal • There are no relevant financial relationships with any commercial Vaginal Bleeding interests to disclose Michael Policar, MD, MPH Professor of Ob, Gyn, and Repro Sciences UCSF School of Medicine [email protected] Vulvovaginal Symptoms: CDC 2010: Trichomoniasis Differential Diagnosis Screening and Testing Category Condition • Screening indications – Infections Vaginal trichomoniasis (VT) HIV positive women: annually – Bacterial vaginosis (BV) Consider if “at risk”: new/multiple sex partners, history of STI, inconsistent condom use, sex work, IDU Vulvovaginal candidiasis (VVC) • Newer assays Skin Conditions Fungal vulvitis (candida, tinea) – Rapid antigen test: sensitivity, specificity vs. wet mount Contact dermatitis (irritant, allergic) – Aptima TMA T. vaginalis Analyte Specific Reagent (ASR) Vulvar dermatoses (LS, LP, LSC) • Other testing situations – Vulvar intraepithelial neoplasia (VIN) Suspect trich but NaCl slide neg culture or newer assays – Psychogenic Physiologic, psychogenic Pap with trich confirm if low risk • Consider retesting 3 months after treatment Trichomoniasis: Laboratory Tests CDC 2010: Vaginal Trichomoniasis Treatment Test Sensitivity Specificity Cost Comment Aptima TMA +4 (98%) +3 (98%) $$$ NAAT (like GC/Ct) • Recommended regimen Culture +3 (83%) +4 (100%) $$$ Not in most labs – Metronidazole 2 grams PO single dose Point of care – Tinidazole 2 grams PO single dose •Affirm VP III +3 +4 $$$ DNA probe • Alternative regimen (preferred for HIV infected
  • Current Evaluation of Amenorrhea

    Current Evaluation of Amenorrhea

    Current evaluation of amenorrhea The Practice Committee of the American Society for Reproductive Medicine Birmingham, Alabama Amenorrhea is the absence or abnormal cessation of the menses. Primary and secondary amenorrhea describe the occurrence of amenorrhea before and after menarche, respectively. (Fertil Steril௡ 2006;86(Suppl 4):S148–55. © 2006 by American Society for Reproductive Medicine.) Amenorrhea is the absence or abnormal cessation of the menses complaint. The sexual ambiguity or virilization should be (1). Primary and secondary amenorrhea describe the occurrence evaluated as separate disorders, mindful that amenorrhea is of amenorrhea before and after menarche, respectively. The an important component of their presentation (9). majority of the causes of primary and secondary amenorrhea are similar. Timing of the evaluation of primary amenorrhea EVALUATION OF THE PATIENT recognizes the trend to earlier age at menarche and is therefore History, physical examination, and estimation of follicle indicated when there has been a failure to menstruate by age 15 stimulating hormone (FSH), thyroid stimulating hormone in the presence of normal secondary sexual development (two (TSH), and prolactin will identify the most common causes standard deviations above the mean of 13 years), or within five of amenorrhea (Fig. 1). The presence of breast development years after breast development if that occurs before age 10 (2). means there has been previous estrogen action. Excessive Failure to initiate breast development by age 13 (two standard testosterone secretion is suggested most often by hirsutism deviations above the mean of 10 years) also requires investiga- and rarely by increased muscle mass or other signs of viril- tion (2).
  • Association Between Menstrual Disorders and Obesity

    Association Between Menstrual Disorders and Obesity

    ArchiveInt J School of Health SID. 2018 April; 5(2):e65716. doi: 10.5812/intjsh.65716. Published online 2018 April 17. Research Article Association Between Menstrual Disorders and Obesity-Related Anthropometric Indices in Female High School Students: A Cross-Sectional Study Mostafa Rad,1 Marzieh Torkmannejad Sabzevary,2 and Zahra Mohebbi Dehnavi3,* 1Faculty of Nursing and Midwifery, Sabzevar University of Medical Sciences, Sabzevar, IR Iran 2Mobini Hospital, Sabzevar University of Medical Sciences, Sabzevar, IR Iran 3Faculty of Nursing and Midwifery, Isfahan University of Medical Sciences, Isfahan, IR Iran *Corresponding author: Zahra Mohebbi Dehnavi, Department of Midwifery and Reproductive Health, Faculty of Nursing and Midwifery, Isfahan University of Medical Sciences, Isfahan, IR Iran. Tel: +98-9139752086, E-mail: [email protected] Received 2018 January 02; Revised 2018 April 11; Accepted 2018 April 13. Abstract Background: The menstrual cycle determines the health of women. Menstrual disorders are a major Geneologic problem among women, especially adolescents, which is a major source of anxiety for them and their families. Factors such as BMI, exercise, and stress can be related to menstrual disorders. As a result, this study was conducted to determine the association between menstrual disorders and anthropometric indices in Female High School Students. Methods: This descriptive cross-sectional study was conducted in Sabzevar on 200 high school female students in 2017. The partici- pants first completed the personal, midwifery,
  • Impact of Anemia on Menstruation and Academic Performance of Adolescent Girls Attending Secondary Schools of Rural Wardha District 1Rufina Binoy,2 Neema Acharya

    Impact of Anemia on Menstruation and Academic Performance of Adolescent Girls Attending Secondary Schools of Rural Wardha District 1Rufina Binoy,2 Neema Acharya

    WJOA Impact of Anemia on Menstruation and Academic10.5005/jp-journals-10065-0001 Performance of Adolescent Girls ORIGINAL ARTICLE Impact of Anemia on Menstruation and Academic Performance of Adolescent Girls attending Secondary Schools of Rural Wardha District 1Rufina Binoy,2 Neema Acharya 3 ABSTRACT adolescents, and women of childbearing age group. Anemia is a common nutritional problem in adolescents.4 In this research, we hope to understand the Introduction: Very few studies focus on adolescent girls’ health, in view effect of anemia on the various menstrual parameters and disorders and on the academic performance of adolescent of that the present study was taken up to throw light on girls attending secondary schools of rural Wardha. the prevalence of anemia in the rural district of Wardha Materials and methods: Questionnaires were prepared and and to assess the effect of the same on their menstrual distributed to the female students who came to attend the health and academic performance. adolescent clinic in Acharya Vinoba Bhave Rural Hospital, Sawangi, India, for health checkup. Their hemoglobin was estimated and recorded in their respective questionnaires. MATERIALS AND METHODS Questionnaires were designed to understand in the best way possible the effects of anemia on the menstrual health and • Site: The research was conducted in Acharya Vinoba academic life of the adolescent girls. Bhave Rural Hospital (AVBRH), Sawangi, Wardha, Results: The results revealed a remarkable correlation India. between the grades of anemia and poor menstrual health; a • Type of study: Questionnaire-based study similar result was seen in case of academic performance as • Duration: 6 months well.
  • Epidemiology of Menstrual Disorders in Developing Countries: a Systematic Review

    Epidemiology of Menstrual Disorders in Developing Countries: a Systematic Review

    BJOG: an International Journal of Obstetrics and Gynaecology DOI: 10.1046/j.1471-0528.2003.00012.x January 2004, Vol. 111, pp. 6–16 REVIEW Epidemiology of menstrual disorders in developing countries: a systematic review Introduction Information on the prevalence of menstrual complaints in the past three months was obtained in seven countries In developing countries, priority setting in the health (Table 1). These data permit cross national comparisons sector traditionally focuses on the principal causes of mor- in so far as similar questions with a similar time reference tality. More recently, the Global Burden of Disease approach were asked. However, no definitions were provided and incorporates assessment of morbidity and quality of life in considerable variation in the interpretation of questions identifying priorities. Yet, although investigations in various among individuals and across cultures is likely. developing countries reveal that women are concerned by Approximately a dozen subsequent surveys, including menstrual disorders, little attention is paid to understanding community-based, clinic-based and one national census, or ameliorating women’s menstrual complaints.1 Menstrual include some information on menstrual morbidities6–29 dysfunction, like other aspects of sexual and reproductive (Table 2). A few health surveys of special populations, health, is not included in the Global Burden of Disease such as factory workers in Vietnam17 and medical students estimates2,3 and, even as reproductive health programs in Venezuela,27,28 have also included relevant questions expand their focus to address gynaecologic morbidity, the on menstrual disorders. These surveys vary consider- utility of evaluating and treating menstrual problems is ably in the definition of and reference period for men- not generally considered.
  • Abnormal Uterine Bleeding: a Management Algorithm

    Abnormal Uterine Bleeding: a Management Algorithm

    J Am Board Fam Med: first published as 10.3122/jabfm.19.6.590 on 7 November 2006. Downloaded from EVIDENCED-BASED CLINICAL MEDICINE Abnormal Uterine Bleeding: A Management Algorithm John W. Ely, MD, MSPH, Colleen M. Kennedy, MD, MS, Elizabeth C. Clark, MD, MPH, and Noelle C. Bowdler, MD Abnormal uterine bleeding is a common problem, and its management can be complex. Because of this complexity, concise guidelines have been difficult to develop. We constructed a concise but comprehen- sive algorithm for the management of abnormal uterine bleeding between menarche and menopause that was based on a systematic review of the literature as well as the actual management of patients seen in a gynecology clinic. We started by drafting an algorithm that was based on a MEDLINE search for rel- evant reviews and original research. We compared this algorithm to the actual care provided to a ran- dom sample of 100 women with abnormal bleeding who were seen in a university gynecology clinic. Discrepancies between the algorithm and actual care were discussed during audiotaped meetings among the 4 investigators (2 family physicians and 2 gynecologists). The audiotapes were used to revise the algorithm. After 3 iterations of this process (total of 300 patients), we agreed on a final algorithm that generally followed the practices we observed, while maintaining consistency with the evidence. In clinic, the gynecologists categorized the patient’s bleeding pattern into 1 of 4 types: irregular bleeding, heavy but regular bleeding (menorrhagia), severe acute bleeding, and abnormal bleeding associated with a contraceptive method. Subsequent management involved both diagnostic and treatment interven- tions, which often occurred simultaneously.
  • Too Much, Too Little, Too Late: Abnormal Uterine Bleeding

    Too Much, Too Little, Too Late: Abnormal Uterine Bleeding

    Too much, too little, too late: Abnormal uterine bleeding Jody Steinauer, MD, MAS July, 2015 The Questions • Too much (& too early or too late) – Differential and approach to work‐up – Does she need an endometrial biopsy (EMB)? – Does she need an ultrasound? – How do I stop peri‐menopausal bleeding? – Isn’t it due to the fibroids? • Too fast: She’s hemorrhaging—what do I do? • Too little: A quick review of amenorrhea Case 1 A 46 yo G3P2T1 reports her periods have become 1. What term describes increasingly irregular and heavy her symptoms? over the last 6‐8 months. 2. Physiologically, what Sometimes they come 2 times causes this type of per month and sometimes there bleeding pattern? are 2 months between. LMP 2 3. What is the months ago. She bleeds 10 days differential? with clots and frequently bleeds through pads to her clothes. She occasionally has hot flashes. She also has diabetes and is obese. Q1: In addition to a urine pregnancy test and TSH, which of the following is the most appropriate test to obtain at this time? 1. FSH 2. Testosterone & DHEAS 3. Serum beta‐HCG 4. Transvaginal Ultrasound (TVUS) 5. Endometrial Biopsy (EMB) Terminology: What is abnormal? • Normal: Cycle= 28 days +‐ 7 d (21‐35); Length=2‐7 days; Heaviness=self‐defined • Too little bleeding: amenorrhea or oligomenorrhea • Too much bleeding: Menorrhagia (regular timing but heavy (according to patient) OR long flow (>7 days) • Irregular bleeding: Metrorrhagia, intermenstrual or post‐ coital bleeding • Irregular and Excessive: Menometrorrhagia • Preferred term for non‐pregnant bleeding issues= Abnormal Uterine Bleeding (AUB) – Avoid “DUB” ‐ dysfunctional uterine bleeding.
  • Age and Fertility: a Guide for Patients

    Age and Fertility: a Guide for Patients

    Age and Fertility A Guide for Patients PATIENT INFORMATION SERIES Published by the American Society for Reproductive Medicine under the direction of the Patient Education Committee and the Publications Committee. No portion herein may be reproduced in any form without written permission. This booklet is in no way intended to replace, dictate or fully define evaluation and treatment by a qualified physician. It is intended solely as an aid for patients seeking general information on issues in reproductive medicine. Copyright © 2012 by the American Society for Reproductive Medicine AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE Age and Fertility A Guide for Patients Revised 2012 A glossary of italicized words is located at the end of this booklet. INTRODUCTION Fertility changes with age. Both males and females become fertile in their teens following puberty. For girls, the beginning of their reproductive years is marked by the onset of ovulation and menstruation. It is commonly understood that after menopause women are no longer able to become pregnant. Generally, reproductive potential decreases as women get older, and fertility can be expected to end 5 to 10 years before menopause. In today’s society, age-related infertility is becoming more common because, for a variety of reasons, many women wait until their 30s to begin their families. Even though women today are healthier and taking better care of themselves than ever before, improved health in later life does not offset the natural age-related decline in fertility. It is important to understand that fertility declines as a woman ages due to the normal age- related decrease in the number of eggs that remain in her ovaries.